Surgical Safety Technologies Rebrands as Aimbient, Broadens Ambient AI Platform
Rebranding signifies a shift towards continuous intelligence before, during, and after procedures to support clinical workflows
Read More
Watch: RFK Jr. Dismisses All 17 Members of Vaccine Advisory Committee
Health and Human Services Secretary Robert F. Kennedy Jr. announced on June 9 he is removing the entire independent committee that advises the Centers for Disease Control and Prevention on vaccine usage, claiming members had too many outside conflicts. KFF Health News’ Céline Gounder joined CBS Evening News to discuss what this means for the…
State of Claims 2024: Insights from survey findings
Despite increased access to claims management technology, claims denials are still on the rise in 2024. Contributing factors include growing healthcare costs, stricter payer reimbursement policies, and claims processing errors. Providers are seeing an uptick in nonpayment, plus an added burden on administrative staff, disrupted patient care, and hits to the bottom line. Experian Health…
Cut Through The Hype: 3 Things To Know Before Adopting Agentic AI
“Agentic AI” is the next solution to help fix what healthcare has been focused on for years – connecting patients to care easily and efficiently, while reducing staff burden. The post Cut Through The Hype: 3 Things To Know Before Adopting Agentic AI appeared first on MedCity News.
Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use to Rare Blood Vessel Disorder
Novartis’s Cosentyx failed to beat a placebo in a Phase 3 clinical trial in giant cell arteritis. The antibody drug was being developed as an alternative to Roche and AbbVie drugs whose approved uses include treating this autoimmune disorder affecting blood vessels. The post Blockbuster Novartis Drug Fails Key Test Hoped to Expand Its Use…
Startup OncoSwab Aims to Make Lung Cancer Detection as Simple as Flu & Covid-19 Tests
Inspired by the speed and ease of at-home Covid-19 tests, OncoSwab is developing a test for lung cancer that detects signs of the disease from a nasal swab. The test could become an alternative to the medical imaging currently used to screen for lung cancer. The post Startup OncoSwab Aims to Make Lung Cancer Detection…
The Hidden Cost of “Good Enough” in Healthcare Experiences
It’s not low effort or underinvestment. It’s the steady-state output of an organization succeeding at the wrong thing. The post The Hidden Cost of “Good Enough” in Healthcare Experiences appeared first on MedCity News.
Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials
Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for underrepresented patients. The post Nearly 200 Organizations Back Bill to Expand Access to Clinical Trials appeared first on MedCity News.
Supply Chain Startup SpendRule Launches With 4 Health System Customers
Backed by Abundant Venture Partners, company focuses the power of AI on helping health systems prevent overpayments on purchased services
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates. The post Merck Is Paying $588M for…